Showing results (91-100 of 279) with videos related to
Sort By:
Pageof 28
Medical Oncology (Northwood, London, England)|July 21, 2012
A retrospective study of SBRT of metastases in patients with primary sarcomaChristina Linder Stragliotto, Kristin Karlsson, Ingmar Lax, et al.Breast Cancer Research and Treatment|July 15, 2010
HER2 status in a population-derived breast cancer cohort: discordances during tumor progressionUlla Wilking, Eva Karlsson, Lambert Skoog, et al.Breast Cancer Research : BCR|July 8, 2014
Sequencing of breast cancer stem cell populations indicates a dynamic conversion between differentiation states in vivoDaniel Klevebring, Gustaf Rosin, Ran Ma, et al.Oncotargets and Therapy|December 4, 2010
Sorafenib inhibits tumor growth and vascularization of rhabdomyosarcoma cells by blocking IGF-1R-mediated signalingWessen Maruwge, Pádraig D'Arcy, Annika Folin, et al.Breast Cancer Research : BCR|July 6, 2018
Identification and validation of single-sample breast cancer radiosensitivity gene expression predictorsMartin Sjöström, Johan Staaf, Patrik Edén, et al.Cancers|April 3, 2021
Variability in Breast Cancer Biomarker Assessment and the Effect on Oncological Treatment Decisions: A Nationwide 5-Year Population-Based StudyBalazs Acs, Irma Fredriksson, Caroline Rönnlund, et al.Oncogene|June 26, 2020
A pan-cancer analysis of the frequency of DNA alterations across cell cycle activity levelsArian Lundberg, Linda S Lindström, Joel S Parker, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 20, 2007
Incidence and prognosis of synchronous and metachronous bilateral breast cancerMikael Hartman, Kamila Czene, Marie Reilly, et al.Genes, Chromosomes & Cancer|October 18, 2006
Gene expression in 16q is associated with survival and differs between Sørlie breast cancer subtypesKristian Wennmalm, Stefano Calza, Alexander Ploner, et al.Scientific Reports|July 3, 2024
Five-year follow-up of the OptiTrain trial on concurrent resistance and high-intensity interval training during chemotherapy for patients with breast cancerPoorna Anandavadivelan, Sara Mijwel, Maria Wiklander, et al.Pageof 28